Introduction
Collecting patient-reported outcomes (PROs), including health-related quality of life (HRQOL), is recommended for cancer comparative effectiveness research [1] . A significant challenge to the use of patient-reported data in cancer care is that patient illness or treatment side effects may affect the ability to complete measures, resulting in unavailable or missing data. Using proxy respondents such as family members is a commonly suggested strategy to address this problem [2] [3] [4] . Proxy respondents have been used in clinical trials [5] as well as national health surveys [6] [7] [8] [9] [10] [11] [12] . However, if proxies are unable to accurately report from the patient's perspective, this can produce a misleading picture. Previous reviews [13] [14] [15] have considered this issue across a range of diseases, including cancer, as well as proxy types (health care professionals treating the patient and family/other non-health care proxies). Most cancerspecific reviews have focused on end of life care [16, 17] . Few, if any, reviews have looked at instrument-specific issues related to proxies. Results have been summarized across instruments and diseases, and tool-specific advice is lacking. The aim of this review is to examine the extent of evidence for family or other non-health professional caregiver proxy reporting for validated multi-dimensional 1 3 HRQOL tools in adult oncology, in order to guide researchers who may need or want to employ proxy reports.
Materials and methods

Search strategy
Following search strategy review by a librarian, we searched PubMed, CINAHL and PsycINFO using a combination of terms for proxy, quality of life, and cancer (Appendix 1). We also perused the bibliographies of articles selected for review to identify additional papers. The search was conducted in March-April 2015, and repeated in February 2016 to ensure no new articles were missed.
Study selection
One reviewer (JKR) selected papers for full-text review based on paper title and abstract, if available. The focus at this stage was including all possible articles and thus articles were selected for full-text review even if there was uncertainty about an article's eligibility. Abstrackr [18] , an open-source screening tool for systematic reviews [19] , was used to manage abstract selection and review. Duplicate citations were identified using EndNote. Commentaries or editorials about previously identified articles were considered to be duplicates.
Articles were eligible for inclusion if: (1) the population studied was adult patients with diagnosed cancer, and the proxies were not exclusively health care professionals responsible for the medical/nursing care of the patient; (2) HRQOL was evaluated using a standardized, quantitative multi-dimensional instrument validated in a cancer patient population; (3) the proxy assessed the patient's HRQOL and patient-proxy concordance of patient HRQOL was evaluated; (4) the full manuscript was available in the English language; (5) the article was original research and not an existing systematic review or meta-analysis; (6) if diseases in addition to cancer were included, cancer-specific results for all outcomes of interest were available. Studies that used both family/non-health care professional proxies and treating physicians/nurses were eligible if the two proxy types were differentiated and results were available for the family/non-health care proxy group. After all authors (JKR, IBW) reviewed the selection criteria, one reviewer (JKR) was responsible for review and data extraction. Data extraction was validated by an experienced researcher, who reviewed 8 (25%) of the extracted articles following training on two articles. Disagreements or different conclusions were discussed. For basic study information (e.g. countries, analytic cohort size, time from treatment to questionnaire administration, etc), no disagreements occurred. The validation identified one error in questionnaire administration timing, which was corrected. No disagreements were identified regarding the extraction of means and correlation coefficients. There were minor disagreements regarding how to consider the minimal clinically important difference in two papers, but these were resolved following discussion. Study authors were not contacted.
Data extraction
A customized Google spreadsheet (gsheet) developed by one reviewer (JKR) was used for full-text decisions and data extraction. We recorded the following information in data extraction: (1) HRQOL tool; (2) study design; (3) patient clinical characteristics (cancer type, cancer stage, treatment status, setting); (4) sample size; (5) if a minimal clinically important difference (MCID) was used to interpret concordance; (6) concordance assessment methods and results for three domains: global/overall QOL, emotional, and physical; (7) factors associated with concordance. For treatment status, treatment setting and MCID, unless studies explicitly noted these, they were considered unspecified. For factors associated with concordance, if proxy type (health professional vs not) was used as a factor for agreement, this was not considered or extracted. Results for other factors were still extracted, but the co-mingling of health care and non-health care proxies noted. Significance for factors, where evaluated, was only reported for the domains of interest (QOL, physical, and emotional). Where authors did not present all factors in tabular form, or used language such as "factors included," we considered factors to be presented elsewhere in the tables/text as evaluated.
For the three domains, if a tool did not have an explicit physical/QOL/emotional scale, we used the scale and/or item which would be most appropriate for that domain. For example, the EQ-5D does not have a specific physical domain, but it does assess mobility; we therefore used this for the physical domain. Additionally, if authors did not provide information regarding summary scales, then the most appropriate subscale within the measure that mapped to the domains of interest was evaluated. The specific items/scales for each domain of interest in the included studies are in Table 1 . As indicated by Table 1 , the domains of these questionnaires covered very different topics.
When possible, the limits of agreement (LOA) were calculated to identify the extent to which patient and proxy responses diverged on average. If a mean difference between patient-proxy responses and associated standard deviation (SD) was available, the LOA were calculated as +/− 1.96 × SD. Where only proxy mean and SD and patient mean and SD were available, the mean difference was calculated by subtracting the two means. For ease of presentation, all mean differences were converted to absolute values. In cases where insufficient information was provided, a simplifying assumption of no covariance (e.g. mean variance equal to the difference of the two variances, calculated as the square of the two provided SDs) was made to facilitate LOA calculations. The LOA were then calculated as +/− 1.96 × SD. As this calculation is an approximation and makes assumptions, all imputed LOAs and mean differences are noted when they appear. In several cases, the authors provided mean differences but not SDs; the calculation for the SD was then undertaken as described above. These cases are also considered to be imputed and noted as such. Descriptions of study scoring were taken from the studies reporting them, study scoring manuals or relevant published papers. All analyses were conducted at 
Results
Study selection and data extraction
The database searches yielded 6614 unique (non-duplicate) abstracts. From these, 202 papers were selected for full-text review (Fig. 1) . Twenty-nine papers were eligible for data extraction; the primary reasons for non-eligibility were proxy not assessing patient HRQOL (n = 80 papers) and the use of study-specific tools or qualitative assessments (n = 40 papers). A further three articles were identified from bibliographic searching, and data were extracted from a total of 32 papers. Three pairs of papers assessed the same study population, either as separate analyses or sub-studies of a main study, yielding a total of 29 unique studies/populations.
Characteristics of included studies
Most papers (N = 20, 63%) were cross-sectional (Table 2) . Most studies came from either Europe (N = 14, 44%), primarily the Netherlands, or North America (N = 13, 41%), primarily the USA. Half of the papers included a range of cancer types; among studies focused on a single disease, prostate and brain cancer were the most common. Care settings were infrequently specified (N = 15, 47%). Most papers (N = 19, 59%) used disease-specific tools: the European Organisation for Research and Treatment of Cancer (EORTC) (N = 11, 34%) [33, [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] , Functional Assessment of Cancer Therapy (FACT)/Functional Assessment Baseline reported for all longitudinal studies. This is the overall analytic cohort, numbers analyzed may vary per outcome e "Spouses" encompasses both spouses and partners f Analyses presented here are restricted to those relevant to proxy-patient concordance. For example, test-retest reliability within patients only would not be included. Analyses relating to factors affecting concordance are presented in Table 6 and not described here 1 3
of Chronic Illness Therapy (FACIT) (N = 7, 22%) [47] [48] [49] [50] [51] [52] [53] , Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) (N = 1, 3%) [43] , and Quality of Life Index (QLI) (N = 1, 3%) [54] . A variety of generic tools (N = 8, 25%) were used, including the Short Form-36 (SF-36) (N = 2, 6%) [55, 56] , the EuroQol five dimensions questionnaire (EQ-5D) (N = 1, 3%) [33] , the World Health Organisation Quality of Life Assessment-Bref (WHOQOL-BREF) (N = 2, 6%) [36, 57] , and the Primary Care Cooperative Information Project/World Organization of National Colleges, Academies, and Academic Associations of General Practices/Family Physicians (COOP/WONCA) (N = 3, 9%) [32, 58, 59] . Of the papers using end-of-life specific tools (N = 6, 19%), most employed the McGill Quality of Life (MQOL) (N = 3, 9%) [29, 60, 61] , followed by the Spitzer Quality of Life Index (SQLI) (N = 2, 6%) [31, 62] and the Hospice Quality of Life Index (HQLI) (N = 1, 3%) [27] . For those studies not restricted to spouses/partners as proxies, spouses usually comprised half or more of the proxies. Baseline dyad sizes were variable, ranging from 23 dyads (N = 46 respondents total) to 614 dyads (N = 307 respondents total). Attrition was frequent and substantial for longitudinal papers, ranging from 12% to 61% missing at the first follow up. Reporting is restricted to baseline data in light of this selection bias and to facilitate comparison with the majority of the papers, which were cross-sectional. When studies discussed the instructions provided for the proxies to answer questionnaires, the instructions were to view the questions from the patient's perspective. The exception were two studies [33, 41] which explicitly evaluated both the aforementioned "proxy-patient" perspective and "proxy-proxy" perspective [33] , in which the proxy approached the questions from their own perspective. To facilitate comparability, all reported estimates are from the "proxy-patient" perspective.
Methodological evaluation of included studies
Methodological reporting was inconsistent across papers. Of the papers which were not pre-treatment (N = 29, 91%), N = 12 (41% of that group) specified the timing of questionnaire administration relative to treatment or hospice admission. Most papers (N = 17, 53%) specified timing relative to diagnosis. Questionnaires were specified as consistently administered at the same time/on the same day for patients and proxies in N = 13 papers (41%), while N = 9 (28%) did not specify and N = 10 (31%) noted that they were not consistently administered at the same time. While N = 12 papers (38%) considered a MCID, N = 15 papers (47%) evaluated the factors associated with proxy/patient concordance. Reporting of missing item data was infrequent, with many papers (N = 19, 59%) not discussing this explicitly. None of the longitudinal papers which discussed unit/ form-level missingness (N = 9) used imputation, instead relying on listwise deletion methods such as complete or available case analysis.
Many papers (N = 25, 78%) compared patient and proxy means, typically through t tests or similar approaches (e.g. Wilcoxon signed-rank test). Comparison of means using effect size was undertaken in N = 15 (47%) papers, and N = 27 (84%) papers evaluated the correlation of patient and proxy scores. When correlation was evaluated, the intra-class correlation (ICC) was the most frequently employed approach (N = 17, 63% of papers evaluating correlation), followed by Pearson's r (N = 9, 33% of papers evaluating correlation) and the weighted kappa (N = 4, 15% papers evaluating correlation).
Patient/proxy concordance: disease-specific instruments
For the EORTC QLQ-C30 (or its predecessor, the QLQ-C36), the mean differences between patient and proxy estimates for the three domains of interest were generally small, and patient estimates were higher than proxy estimates (Table 3) . However, standard deviations were large and spanned at least 20% of the scale for both patient and proxy estimates as well as the differences between them. Patient mean scores were higher/better for all scales in all studies. In other words, proxy estimation of patient physical and emotional function, QOL and the total score was lower on average than the patient's estimation. ICCs for each of the domains suggested moderate correlation, with the strongest correlations and narrowest range for physical function. For global QOL, ICCs ranged from 0.15 to 0.64 (mean 0.46); for physical function, the range was 0.36-0.73 (mean 0.62), and for emotional function the range was 0.14-0.62 (mean 0.47).
For the FACIT/FACT suite, just five of the seven papers provided at least one mean score of some kind, and of these just three provided means for the sub-domains of interest as opposed to the total score. As studies used a variety of disease-specific tools (FACIT-Sp, FACT-G, FACT-P, FACTBr), the maximum total scale score ranged from 112 to 200. Patient mean scores consistently exceeded proxy mean scores, and SDs again comprised a high percentage of the scale. Higher patient mean scores once again reflected patients reporting higher levels of function/QOL, compared to what proxies reported for them. The sole exception to this was one study in which patient and proxy mean scores for QOL were the same [49] . ICCs for each domain and the total score suggested moderate correlation, although correlations were weakest and the range widest for emotional well-being. The range for functional well-being was 0.45-0.73 (mean 0.60); for total score, it was 0.42-0.62 (mean 0.53); for physical well-being, 0.37-0.72 (mean 0.53), and for emotional well-being 0.07-0.58 (mean 0.35).
Higher proxy scores, relative to patient scores, were seen for the other two disease-specific instruments, the PROSQOLI and QLI. This was not consistent for the PROSQOLI, as proxies reported higher (better) scores for the physical domain but patients reported higher (better) scores for the emotional domain. The correlation for the PROSQOLI physical domain was moderate (0.4), but weak for the emotional domain (0.12). No ICC was available for the QLI.
Patient/proxy concordance: end-of-life-specific instruments
For the MQOL, study results for the physical and psychological domains were inconsistent. There was a difference in correlations between the two studies, with one study [29] having consistently moderate correlations (0.47 for the physical domain, 0.36 for the psychological, and 0.61 for the total score), while the other [60] had low to moderate correlations (0.14 for the physical, 0.37 for the psychological and 0.28 for the total score). For the MQOL total score and psychological score, in both studies patient mean scores were higher than proxy scores, reflecting higher patient-reported QOL and psychological well-being, relative to proxy-reported scores. However, in one study the patients' mean physical scale score was higher [60] , indicating patients reporting higher/better physical well-being compared to what proxies reported for them, but in another the proxy score was higher [29] .
None of the papers using the Spitzer QLI or Hospice QLI assessed an ICC. For the total score, where means for each group were provided [27, 62] , the patient score was higher than the proxy score. One study using the Spitzer QLI [31] provided means for individual domains (which are items in the questionnaire), but no SDs; for both of these domains, the patient mean score was higher, indicating better QOL. However, as with other measures, the LOA were wide and encompassed a substantial proportion of the scale (Table 4) .
Patient/proxy concordance: generic instruments
ICCs were infrequently reported for generic instruments. Only three papers included an ICC assessment [32, 33, 59] , two of which used the COOP/WONCA [32, 59] and were drawn from the same study population. For the COOP/ WONCA, all ICCs were moderate: global quality of life (0.37 and 0.48), physical (0.56 and 0.57) and emotional (0.48 and 0.48). For the EQ-5D, ICCs were low (0.29) for emotional and moderate (0.46) for physical. As noted in Table 1 , the physical domain for the EQ-5D refers to the assessment of mobility, while the emotional domain refers to the assessment of anxiety/depression. Usable mean differences were reported for the COOP/ WONCA, WHOQOL-BREF and EQ-5D only (Table 5) . Once again, LOA were very wide even though mean differences were relatively small (≤0.5 points on a 1-5 point scale, for example). For the COOP/WONCA, ICCs for all domains were moderate: 0.37 and 0.48 for global QOL; 0.56 and 0.57 for the physical domain; and 0.48 for the emotional domain.
For the COOP/WONCA, higher scores meant worse QOL, physical fitness, or feelings. Patient mean scores were lower, indicating better QOL/fitness/feelings, for all studies save one [58] , where the proxy and patient mean scores were identical. In the one study using the EQ-5D [33] , patient mean scores were higher than proxy mean scores, reflecting better patient-perceived QOL compared to proxy-perceived QOL. Results for the WHOQOL-BREF were less consistent. For the QOL domain, in both studies proxies reported higher/better QOL compared to patient reports, although the differences were small. For the physical and psychological domains, however, patient mean scores were higher/better.
Assessment of factors associated with concordance
Of the 15 papers evaluating factors associated with proxy/ patient concordance, there are 13 unique patient populations/studies as two pairs of papers are each analyzing the same population or a sub-set thereof in different ways. In one case, one [59] is a subset of the other [32] , focusing on an inpatient group when the main study assessed both inpatients and outpatients. In the second set, one study [41] conducted an additional evaluation of the role of proxy viewpoint on concordance in a group of respondents from an earlier study [42] .
Most of the papers conducting this analysis used the EORTC QLQ-C30 (N = 5), followed by the MQOL (N = 2), the SF-36 (N = 2) and the COOP/WONCA (N = 2). Other evaluated tools were the FACT-G (N = 1), WHOQOL-BREF (N = 1), Spitzer QLI (N = 1), EQ-5D (N = 1) and Hospice QLI (N = 1). Due to the sub-studies mentioned above, the number of unique studies/patient populations is lower for two measures: the EORTC (N = 4 studies, N = 5 papers) and the COOP/WONCA (N = 1 study, N = 2 papers).
Proxy factors were evaluated in 11 papers. As Table 6 shows, a range of methods and factors were used. Statistical significance was evaluated, often through t tests or correlation. Multivariable analyses were conducted in N = 4 papers. The patient-proxy relationship was frequently considered as a factor (N = 7 studies), usually by comparing a spouse/partner proxy to other proxies such as children or friends. Results on the effect of the patient/proxy relationship on concordance could not be Authors note their scale is 0-112 due to the addition of a study-specific item obtained for a further three papers [32, 59, 60] , as for that analysis they did not separate health care and nonhealth care proxies. One paper [57] could not evaluate this as proxy selection criteria included a restriction to spouses/partners. Two studies found statistically significant proxy-patient mean score differences relating to spousal proxies. In one study [48] , spouse-patient mean score differences on the total QOL score for the FACT were smaller than that for other proxy types. In the other [55] , spouse-patient differences were statistically significant for the mental health domain of the SF-36, but nonspouse-patient differences were not significant. Finally, one study found that spousal and sibling proxies had significantly better proxy-patient concordance than parental/ child proxies [56] . In this study, concordance was defined as the proxy score being within the 90% confidence interval of the patient score.
A small number of studies considered other factors relating to the patient-proxy relationship, including the length of time the proxies and patients were living together, the frequency and intensity of proxy/patient contact, the quality of the relationship and of proxy-patient communication. The one study evaluating the proxy's perceived knowledge of patient thoughts and feelings on disease and symptoms found it to be negatively associated with concordance (e.g. better knowledge was associated with increased absolute mean differences) in both univariable and multivariable analyses, although the amount of variance explained was low [61] .
Few proxy socio-demographic characteristics also had significant effects on proxy-patient concordance. Five papers evaluated the role of proxy gender, and one paper [57] could not evaluate this as only male partner proxies were included by design. In pairwise analyses, male Table 5 Concordance results across domains-patient vs proxy means, mean differences and limits of agreement (LOA): generic tools SF-36 not included as 1 of the 2 studies using it did not assess mean differences, and the other only did it within subgroups rather than overall proxies were associated with significantly worse concordance (larger absolute proxy-patient differences) for the EORTC QLQ-C30 total score [42] , but better concordance (less disagreement) for the emotional function scale [46] for the same questionnaire. In both of these studies, these associations were not significant in multivariable analyses. Proxy-patient response agreement levels were similar across gender groupings in another study [59] . Older proxies were associated with significantly larger absolute differences for the total score in pairwise analyses, but not in multivariable analyses [42] . Other proxy factors such as education and employment were not significant, although they were also infrequently examined (N = 3 and N = 2 papers, respectively). Proxy health characteristics and caregiving burden had significant, albeit infrequently examined and inconsistent, associations with proxy-patient concordance. Worse proxy HRQOL [42] or the presence of a comorbidity [61] was associated with significantly larger absolute mean differences for the EORTC [42] and MQOL [61] . Higher caregiving burden as measured by the Caregiver Reaction Assessment Tool was associated with worse concordance (larger proxy-patient differences) in two studies in both pairwise and joint multivariable analyses [46, 61] . In one study, this association was found for the domain of impact of caregiving on proxy health [61] , whereas for the other the domains of caregiver self-esteem and lack of family support were significant [46] . The effect for the MQOL was seen for the total score (the only MQOL score considered in that paper), whereas in the other paper effects were seen on the emotional function and QOL scales of the EORTC. Caregiver burden, assessed as the frequency of feeling burdened, was not significantly associated with absolute or directional proxy-patient score differences in another study. However, in that study higher reported caregiving intensity had significant negative associations with both measures (e.g. higher intensity associated with larger differences/worse concordance) in pairwise analyses, and a significant association in multivariable models for directional difference [42] .
The two papers [33, 41] evaluating the impact of proxy viewpoint in instructions and questions had inconsistent results and neither the proxy-proxy nor the patient-proxy view was associated with better concordance on all evaluated scales. In one study, significant mean score differences between perspectives were found for the emotional and physical function scales of the EORTC, as well as for the EQ-5D VAS score [33] . For all these scales, proxy-patient differences were smaller under the proxy-patient perspective. However, in the second study there were no significant between-perspective differences, although both patient and proxy perspectives showed significant mean differences as indicated by t tests for emotional and physical function as well as QOL [41] . In terms of impact of proxy characteristics on how proxy perspectives affected concordance, this was only examined in one study [33] . Limited proxy health literacy was associated with more consistency across perspectives (e.g. smaller differences between the two proxy perspectives tested) for physical function, but proxies with depressive symptoms had significantly lower odds of exact agreement (100% concordance) between perspectives for the EQ-5D VAS than proxies without depressive symptoms.
Patient characteristics were more frequently assessed, although again results were inconsistent, and not significant in many of the assessing studies. As with the evaluation of proxy-specific factors, a range of methods and factors were considered. Although patient age was frequently examined (N = 8 papers), it was significant for both univariable and multivariable analyses in only one study [61] , where older age was associated with smaller mean absolute differences in the MQOL total score. However, older patients had significantly larger absolute proxy-patient differences, relative to younger patients, for the EORTC total score, although the association in multivariable analyses was not significant [42] (Table 7) .
Results for cognitive function were likewise inconsistent. Significantly more proxy-patient discrepancies were found for patients with mental confusion, compared to those with normal function [44] . In addition, significantly lower proxy scores were also found on the physical and emotional function and QOL scales for patients with mental confusion, whereas no significant proxy-patient differences were seen in the group of patients with normal function. Furthermore, worse (lower) proxy-patient agreement, as indicated by both exact agreement (same response category) and approximate agreement (within one response category) was seen for patients with mental confusion in the same study, compared to patients without. In this study, mental confusion was measured using a "newly developed 10-item instrument" administered as part of a neurologic exam. However, the opposite result was seen for patients with brain metastases (compared to those without) on the MQOL total score; the presence of brain metastases was associated with significantly smaller absolute mean differences between patients and proxies [61] . Finally, another study using the MQOL found that patients with poorer function, as measured by the Short Orientation-Memory-Concentration Test, had significantly smaller mean proxy-patient differences (e.g. better agreement) on both the psychological and total scores of the MQOL [60] .
Patient performance status was likewise evaluated using a range of tools, and considered in five papers [32, 42, 44, 59, 60] . It was not significant in one paper [60] . One study used a t test to compare agreement among groups defined by the patient's performance status, as measured by the Eastern Cooperative Oncology Group (ECOG) score. Poorer/worse performance status was associated with significantly smaller differences for physical function and QOL, but significantly larger differences for emotional function [32] . While significance was not considered in another study [59] , larger response agreement discrepancies were seen in patients with a status of ECOG 2 (poor), compared to ECOG 0 (good). Worse ECOG performance status was significantly associated with significantly larger absolute proxy-patient differences on the total EORTC QOL score in another study [42] , although this was not the case for multivariable analyses.
Other aspects of patient health also provided inconsistent results; for example, more depressive symptoms as measured by the Beck Depression Inventory were associated with significantly smaller proxy-patient differences for the psychological scale of the WHOQOL-BREF [57] , but poorer mental health as measured by the Mental Health Inventory-5 was associated with significantly larger absolute differences on the EORTC total score [42] . It was difficult to discern the effect of treatment as nearly half of the papers evaluating the correlates of proxy-patient concordance assessed either hospice or pre-treatment patients or patients receiving the same treatment (N = 7 of N = 15). Patient QOL was considered infrequently; in one proxy-patient correlations in groups defined by patient HQLI score relative to the median score were examined [27] . Significant proxy-patient correlations were found in the higher scoring group, and the correlation in the lower scoring group was both smaller and not significant. One other study looked at patient QOL using scatter plots, and found fewer proxy-patient differences at either extreme end of the patient QOL distribution; in other words, proxy-patient agreement was better if patients had either very good or very bad QOL, but worse if patients had moderate QOL.
Finally, relatively few papers reported on the quality of their models or approaches for evaluating the association between patient or proxy factors and concordance. Those that did noted the relatively low percentage of variance explained, which was <20% [42, 61] .
Discussion
This paper has four main findings. First, group-level patient-proxy concordance as measured by mean differences and correlation is generally good for multidimensional HRQOL tools, although proxies consistently underestimate patient QOL and physical and emotional function compared to patient estimation of these outcomes. Second, despite the good concordance, there was substantial residual variability, suggesting the need to minimize this variability using appropriate adjustment factors. Third, more work is needed to identify additional adjustment factors using standardized measurement approaches and carefully designed protocols. Fourth, while additional work is needed, several tools currently have the strongest evidence base in terms of the extent of information available for concordance and adjustment factors. These are the EORTC QLQ-C30 (disease-specific tools), the MQOL (end-of-lifespecific tools), and the COOP/WONCA (generic tools).
The finding of adequate group-level patient-proxy concordance and small mean differences between patient and proxy scores is consistent with previous reviews [15] [16] [17] 63] . The large levels of residual variability highlight the importance of identifying and using factors to minimize it. For the EORTC results, for example, the mean differences for the QOL scales ranged from 1.8 to 11.27, with four of the ten papers having mean differences ≤4, which is considered a trivial difference [64] . The largest mean difference of 11.27 is considered medium [64] . However, the extremely broad limits of agreement can encompass a large MCID for both scales (>15 points) [64] . While we have suggested the MQOL as an end-of-life-specific tool and the COOP/ WONCA as a generic tool, the evidence base for these tools is relatively weaker than that for the EORTC, as a relatively small number of papers assessed the MQOL and the COOP/WONCA. However, we provided this recommendation due to our interest in discussing both disease-specific and non-disease-specific tools. Additionally, previous work in other populations provides some support for this recommendation. Kutner and colleagues looked at patient-proxy reporting using the MQOL in a hospice population (58% cancer patients) and demonstrated that patient-proxy correlation was moderate and mean differences were small, concluding that proxies could be used if patient responses were not available [65] . We were unable to find studies beyond those already identified in the review which evaluated proxy-patient concordance using the COOP/WONCA. We did identify studies which looked at patient and proxy reporting for the EQ-5D; as only one paper in our review used this measure, we could not provide a recommendation for it. None of the studies we found included cancer patients, and several were comparing health professional caregivers such as physiotherapists and nursing home staff, rather than family caregivers. Comparison of patient EQ-5D scores to proxy scores in frail elderly [66] , community-based individuals with moderate dementia [67] , and elderly patients who had visited the emergency department [68] identified large differences and none of the authors recommended the use of proxy ratings for this instrument.
A caveat to our finding about adequate concordance is that different methods were used across the studies for evaluating concordance. For example, while the weighted kappa and the ICC are equivalent under some conditions [69] , the ICC is preferable to Pearson's r as the latter does not address systematic bias [70] . A related issue is that skewed data, which may be seen in quality of life research, may result in low correlations simply because variability is limited [15] . The range of scores should therefore be taken into consideration and reported when discussing proxy-patient correlation. Furthermore, use of unweighted kappa can be problematic due to the well-known bias and prevalence problems for that measure [69, 70] . While few studies employed graphical approaches such as Bland-Altman plots, these approaches can be helpful for understanding agreement [71] .
The findings of this review suggest that caregiver burden, patient performance status and patient and proxy demographic characteristics should be considered as potential factors. Measurement approaches for these factors should be standardized, especially for factors such as caregiver burden and performance status. Additional exploratory work which examines the potential role of other factors is also needed, as most factors explained a relatively low proportion of variance in the outcome. At a minimum, researchers considering the use of proxy-reported data should collect information on caregiver burden and proxy socio-demographic characteristics such as age and gender. Proxy type should also be collected and reported, unless restricted to a specific type for study design reasons.
This work has several limitations. First, while limiting the included papers to published papers enabled a more thorough assessment of study methods and results, it may have resulted in missing other, potentially relevant findings. Second, exclusion of non-English language papers may have had a similar impact. Third, in many cases methodological issues such as item-level missingness, treatment setting or treatment status were classified as 'unspecified' in cases where papers did not explicitly describe the issue in question. This may result in evaluations of quality being more like evaluations of documentation quality; however, we felt it was more appropriate to classify these as 'not specified' rather than making possibly unsupported assumptions. Fourth, limiting the review to multi-dimensional, validated HRQOL instruments may limit the generalizability of the findings. Fifth, we did not consider itemlevel analyses, which may limit the usefulness of the work.
In conclusion, the moderate concordance between proxy and patient reports suggests that proxy reports can be used by researchers. However, it is important to adjust for the substantial residual variability which remains and researchers are encouraged to consider collecting, at a minimum, factors relating to caregiver burden, patient performance status and patient and proxy demographic characteristics. Standardized collection of such factors in future studies can provide important information about their predictive value and lead to better guidelines regarding proxy data or prox* or "patient agent" or "health care agent" or "healthcare agent" or family or caregiver or "next of kin" or spouse or husband or wife)
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S7 ("Neoplasms" OR cancer* OR cancers or cancerous or neoplasm* OR malignan* or "Medical Oncology") AND (S1 AND S5 AND S6) S1 "Proxy" or prox* or "patient agent" or "health care agent" or "healthcare agent" or family or caregiver or "next of kin" or spouse or husband or wifes
S2
Health-related quality of life OR hrqol OR quality of life OR qol "Quality of Life" or "quality of life" or "quality-of-life" S3 "Quality of Life" or "quality of life" or "quality-of-life" S4 "Neoplasms" OR cancer* OR cancers or cancerous or neoplasm* OR malignan* or "Medical Oncology"
S5 ("Neoplasms" OR cancer* OR cancers or cancerous or neoplasm* OR malignan* or "Medical Oncology") AND (S1 AND S3 AND S4) collection and use. Although gaps in knowledge remain, we recommend that researchers who need to use proxy reports in surveys or other evaluations which will present group-level analyses employ either the EORTC QLQ-C30 (disease-specific), MQOL (end-of-life-specific), or COOP/ WONCA (generic).
